Smokers who quit with the help of e-cigarettes often continue vaping, but it is not known whether this promotes or prevents ...

Chimeric antigen receptor (CAR) T-cell therapy-associated immune-related adverse events (CirAEs) were associated with a high ...

Patients share their experiences with myeloma relapses, discussing coping strategies, emotional challenges, and the ...

A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...

For decades, prevailing wisdom held that to overcome addiction, the most important thing to do was to flush or “clean” the drugs out of one’s system, to get a fresh start. But more and more, research ...

Teclistamab-cqyv significantly improves PFS and OS in multiple myeloma patients with 1 to 3 prior therapies, showing a 71% ...

New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia by identifying the blood cancer's reliance on a specific signaling pathway ...

I never get over the weirdness of introducing myself to a group of people at a 12-step meeting. “Hi, I’m T and I’m an addict,” is how I have started a lot of conversations. Other people in recovery ...

This transcript has been edited for clarity. John Kane, MD: I am Dr John Kane. I am a professor of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, New ...

Nearly everyone with multiple myeloma relapses. That doesn’t make it easy. A cancer diagnosis is traumatic, especially when the cancer is treatable, but not curable. In multiple myeloma, the disease ...